Results 91 to 100 of about 42,840 (198)
The diagnostic pathway of high‐risk primary care patients through NT‐proBNP. Abstract Introduction Early detection of heart failure (HF), particularly in asymptomatic individuals, is essential for timely intervention. This study aimed to determine the prevalence of HF among high‐risk individuals in primary care using N‐terminal probrain natriuretic ...
Ahmet Celik+17 more
wiley +1 more source
Deficiencies in corin and atrial natriuretic peptide-mediated signaling impair endochondral ossification in bone development. [PDF]
Zhou Z+10 more
europepmc +1 more source
Pseudomonas aeruginosa Biofilm Dispersion by the Human Atrial Natriuretic Peptide. [PDF]
Louis M+17 more
europepmc +1 more source
Abstract Aims Right ventricular (RV) remodelling, a progressive condition characterized by maladaptive cardiac structural and functional changes, primarily results from prolonged pressure overload in patients with pulmonary hypertension (PH). Accurate, universal and easy‐to‐use biomarkers for assessing the severity of RV remodelling are lacking.
Xuenan Wang+5 more
wiley +1 more source
Evaluation of plasma atrial natriuretic peptide concentration in healthy bottlenose dolphins (Tursiops truncates). [PDF]
Kinoshita R+5 more
europepmc +1 more source
Clinical implications of atrial natriuretic peptide amyloidosis. [PDF]
Hyer C, Campbell C, Kahwash R.
europepmc +1 more source
Abstract Sodium‐glucose cotransporter‐2 (SGLT2) inhibitors represent one of the main cornerstones of heart failure treatment. Nevertheless, while the cardiovascular beneficial effects of these drugs have been clearly demonstrated by several clinical trials, in clinical practice, it remains challenging to identify the appropriate timing to start SGLT2 ...
Ruggero Mazzotta+10 more
wiley +1 more source
Correction to: Endothelial actions of atrial natriuretic peptide prevent pulmonary hypertension in mice. [PDF]
Werner F+9 more
europepmc +1 more source
Abstract Background Sodium glucose co‐transporter 2 inhibitors (SGLT2i) and mineralocorticoid receptor antagonists (MRA) reduce heart failure (HF) events in patients with heart failure and mildly reduced or preserved ejection fraction (HFmr/pEF). The randomized comparison of SGLT2i/MRA combination versus SGLT2i or MRA alone requires further testing in ...
João Pedro Ferreira+26 more
wiley +1 more source
Plasma Atrial Natriuretic Peptide Predicts Oxidized Low-Density Lipoprotein Levels in Type 2 Diabetes Mellitus Patients Independent of Circulating Adipokine and Cytokine. [PDF]
Bakillah A+9 more
europepmc +1 more source